Incretin Receptor Pharmacology
GLP-1 and GIP are incretin hormones. Receptor agonists are research tools for glucose-dependent insulin secretion, glucagon suppression and gastric-emptying studies.

Explore research products: AOD-9604 · Monera · Rittera · Tesamorelin. Compare available formats and pack sizes.
Explore research products: AOD-9604 · Monera · Rittera · Tesamorelin. Compare available formats and pack sizes.
This category groups the metabolic-research compounds we stock: Tirzepatide, a dual GIP/GLP-1 receptor agonist (sold by Supreme Biologics as Monera); Retatrutide, a GIP/GLP-1/glucagon triple receptor agonist (sold by Supreme Biologics as Rittera); AOD-9604, a modified fragment of the growth-hormone C-terminus (residues 176–191) studied in lipid-metabolism models; and Tesamorelin, a stabilised GHRH analogue. Incretin agonists are used to study glucose-dependent insulin secretion, glucagon signalling and gastric-emptying pathways in preclinical models. Each batch is HPLC verified at ≥99% purity with a batch Certificate of Analysis. Formats include vials, dual-chamber cartridges and multi-dose pens. Semaglutide is not stocked; it appears on our GLP-1 research overview for comparison only. For a mechanism-level comparison, see Retatrutide vs Tirzepatide.
GLP-1 and GIP are incretin hormones. Receptor agonists are research tools for glucose-dependent insulin secretion, glucagon suppression and gastric-emptying studies.
Tirzepatide activates both the GIP and the GLP-1 receptor. Research compares dual agonism with single-receptor agonism in preclinical metabolic models.
Retatrutide adds glucagon-receptor activity to GIP and GLP-1 agonism. It is the newest incretin-class compound in metabolic research.
AOD-9604 is a growth-hormone fragment studied in lipolysis models. Tesamorelin is a GHRH analogue that acts at the pituitary GHRH receptor.
Tirzepatide is a dual GIP/GLP-1 receptor agonist. Retatrutide also activates the glucagon receptor, so it is a triple agonist. Both are supplied for laboratory research only.
Supreme Biologics sells Tirzepatide as Monera and Retatrutide as Rittera. The product page lists the compound name, strength and format for each listing.
No. Semaglutide is not stocked. It is covered only in our research articles as a reference compound.

A Physician's Endorsement
Quality assurance isn't a marketing claim — it's a daily decision. I choose LifeSpanSupply because every batch is independently HPLC-verified to 99% purity, fully traceable, and held to the safety standards my patients deserve.
Dr. Pichaya Sangaunmu
M.D. · Wellness · Beauty · Longevity

Supreme Biologics
Dual-chamber cartridges
Tesamorelin — a synthetic GHRH(1-44) analogue studied in growth hormone axis research. Supreme Biologics dual-chamber cartridges, sold by the box, for laboratory research use only.

Supreme Biologics
Dual-chamber cartridges
Rittera — a single peptide agonist at the GIP, GLP-1 and glucagon receptors. Supreme Biologics dual-chamber cartridges, sold by the box, for laboratory research use only.

Supreme Biologics
Dual-chamber cartridges
Monera — a 39-amino-acid dual GIP and GLP-1 receptor agonist peptide. Supreme Biologics dual-chamber cartridges, sold by the box, for laboratory research use only.

Supreme Biologics
Multi-dose penReady-mixed liquid
AOD-9604 5 mg — a synthetic growth hormone fragment (176–191) studied in lipid-metabolism research. Single-chamber refill for the Supreme Biologics reusable pen, for laboratory research use only.

Supreme Biologics
Multi-dose penReady-mixed liquid
Rittera 5 mg — a single peptide agonist at the GIP, GLP-1 and glucagon receptors. Single-chamber refill for the Supreme Biologics reusable pen, for laboratory research use only.

Supreme Biologics
Multi-dose penReady-mixed liquid
Monera 20 mg — a 39-amino-acid dual GIP and GLP-1 receptor agonist peptide. Single-chamber refill for the Supreme Biologics reusable pen, for laboratory research use only.